Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses
J Poulos, SLT Normand, K Zelevinsky… - Psychological …, 2023 - cambridge.org
BackgroundIndividuals with schizophrenia exposed to second-generation antipsychotics
(SGA) have an increased risk for diabetes, with aripiprazole purportedly a safer drug. Less is …
(SGA) have an increased risk for diabetes, with aripiprazole purportedly a safer drug. Less is …
The incidence of diabetes in atypical antipsychotic users differs according to agent—results from a multisite epidemiologic study
MU Yood, G DeLorenze… - … and drug safety, 2009 - Wiley Online Library
Purpose The purpose of this study was to examine the association between atypical
antipsychotics, including the newer agents, aripiprazole and ziprasidone, and newly treated …
antipsychotics, including the newer agents, aripiprazole and ziprasidone, and newly treated …
Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics
L Citrome, JM Collins, BL Nordstrom… - The Journal of clinical …, 2013 - psychiatrist.com
Objective: To examine the risk of cardiovascular outcomes and diabetes mellitus in patients
prescribed second-generation antipsychotics. Method: From the MarketScan claims …
prescribed second-generation antipsychotics. Method: From the MarketScan claims …
[HTML][HTML] Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia
DA Ollendorf, AT Joyce, M Rucker - Medscape General Medicine, 2004 - ncbi.nlm.nih.gov
Objective: To compare the rates of new-onset diabetes mellitus (DM) between patients
treated for schizophrenia with atypical or conventional antipsychotics. Design: Retrospective …
treated for schizophrenia with atypical or conventional antipsychotics. Design: Retrospective …
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
M Ulcickas Yood, GN DeLorenze, CP Quesenberry… - BMC psychiatry, 2011 - Springer
Background The benefits of some second-generation antipsychotics (SGAs) must be
weighed against the increased risk for diabetes mellitus. This study examines whether the …
weighed against the increased risk for diabetes mellitus. This study examines whether the …
Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case‐control study of California Medicaid claims
BL Lambert, CH Chou, KY Chang… - … and drug safety, 2005 - Wiley Online Library
Purpose To examine the risk of developing type 2 diabetes mellitus among people with
schizophrenia exposed to atypical antipsychotics (clozapine, olanzapine, quetiapine …
schizophrenia exposed to atypical antipsychotics (clozapine, olanzapine, quetiapine …
Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design
F Gianfrancesco, J Pesa, RH Wang… - American journal of …, 2006 - academic.oup.com
Purpose. The effect of study design on findings regarding diabetes risk associated with
antipsychotics was studied. Methods. This study was a retrospective analysis of data from …
antipsychotics was studied. Methods. This study was a retrospective analysis of data from …
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States
PD Feldman, LK Hay, W Deberdt, JS Kennedy… - Journal of the American …, 2004 - Elsevier
OBJECTIVES: The objective of this study was to investigate risk of diabetes among elderly
patients during treatment with antipsychotic medications. DESIGN: We conducted a …
patients during treatment with antipsychotic medications. DESIGN: We conducted a …
First-v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis
BackgroundThe increased prevalence of diabetes in schizophrenia is partly attributed to
antipsychotic treatment, in particular second-generation antipsychotics, but the evidence has …
antipsychotic treatment, in particular second-generation antipsychotics, but the evidence has …
Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia
BL Lambert, FE Cunningham, DR Miller… - American journal of …, 2006 - academic.oup.com
To evaluate risk of new-onset type 2 diabetes associated with use of selected antipsychotic
agents, the authors conducted a new-user cohort study in a national sample of US Veterans …
agents, the authors conducted a new-user cohort study in a national sample of US Veterans …